Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Top Cited Papers
- 25 January 2004
- journal article
- clinical trial
- Published by Springer Nature in Nature Medicine
- Vol. 10 (2) , 145-147
- https://doi.org/10.1038/nm988
Abstract
The effects of vascular endothelial growth factor (VEGF) blockade on the vascular biology of human tumors are not known. Here we show here that a single infusion of the VEGF-specific antibody bevacizumab decreases tumor perfusion, vascular volume, microvascular density, interstitial fluid pressure and the number of viable, circulating endothelial and progenitor cells, and increases the fraction of vessels with pericyte coverage in rectal carcinoma patients. These data indicate that VEGF blockade has a direct and rapid antivascular effect in human tumors.Keywords
This publication has 16 references indexed in Scilit:
- A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal CancerNew England Journal of Medicine, 2003
- Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11British Journal of Cancer, 2003
- Antiangiogenesis drug promising for metastatic colorectal cancerThe Lancet, 2003
- Molecular regulation of vessel maturationNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?Nature Reviews Cancer, 2002
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibodyProceedings of the National Academy of Sciences, 1996
- A systems approach to cancer therapyCancer and Metastasis Reviews, 1996